Search Log in

Cancer Drug Resistance

Open Access  ISSN: 2578-532X (Online)   Editor-in-Chief: Godefridus J. Peters
Indexing: ESCI, PMC, Scopus, CAS, CNKI, Dimensions, Lens, Embase®,
Journal Rank: CiteScore 5.5 - Q2 (Pharmacology(medical))   MPT: 114 days
Home Articles Special Issues Volumes Webinars Videos
Home Articles Special Issues Volumes Webinars Videos
It has reached the top
John Seymour
Peter MacCallum Cancer Centre, Royal Melbourne Hospital & University of Melbourne, Victoria, Australia.
Research Interests
haematology, aggressive lymphoma, acute leukemia, myelodysplasia.
Contributions:

Promises and pitfalls of targeted agents in chronic lymphocytic leukemia

Submit a Manuscript
Manuscript Templates
Aims and Scope
Editorial Board
Submit a Manuscript
Manuscript Templates
Aims and Scope
Editorial Board
Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/
Privacy Cookies Terms of Service Contact Us
Contact Us
partners@oaepublish.com
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2023 OAE Publishing Inc., except certain content provided by third parties